← Back to Search

Behavioural Intervention

Arm A: Enhanced Usual Care for Lung Cancer

N/A

Recruiting

Led By Gelareh Sadigh, MD

Research Sponsored by University of California, Irvine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Aged 50-80 years of age

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up within 3 months after last patient completion of follow-up

Awards & highlights

Study Summary

This trial aims to improve lung cancer screening among Hispanic/Latinx individuals, who currently have limited access to healthcare services. The study will test a multi-level intervention that includes notifying primary care providers about patients

Who is the study for?

This trial is for Hispanic individuals aged 50-80 who are current or former smokers (quit within the last 15 years) with a history of heavy smoking. They must have an upcoming primary care appointment and be able to speak English or Spanish. It's focused on those in Orange County attending UCI Health clinics.Check my eligibility

What is being tested?

The study tests if reminders to patients and providers, patient education, and financial navigation aid can increase lung cancer screenings using low dose CT scans compared to enhanced usual care. The goal is early detection of lung cancer in the Hispanic community.See study design

What are the potential side effects?

Since this trial involves educational interventions rather than medical treatments, there are no direct side effects from medications. However, participants may experience anxiety or stress related to screening outcomes.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 50 and 80 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ within 3 months after last patient completion of follow-up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~within 3 months after last patient completion of follow-up

This trial's timeline: 3 weeks for screening, Varies for treatment, and within 3 months after last patient completion of follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of participants with order of Low-dose CT (LDCT) for lung cancer screening (LCS)

Secondary outcome measures

Number of Participants who received LDCT for LCS

Number of Participants with the documented discussion of lung cancer screening with their providers in the electronic medical record

Patients' knowledge about lung cancer screening

+5 more

Other outcome measures

Patients' experience with intervention

Providers experience with intervention

Trial Design

2Treatment groups

Experimental Treatment

Group I: Arm B: Empower LatinxExperimental Treatment5 Interventions

PCP notifications of patients' LCS eligibility (addressing provider time constraints and barrier in identifying eligible patients); Patients' education (addressing knowledge barriers); Patients' referral to financial navigation resources (addressing health-related social risks) Patients' reminder to discuss LCS during PCP visit.

Group II: Arm A: Enhanced Usual CareExperimental Treatment2 Interventions

Usual Care + Brief Educational Material

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Patient education

2011

Completed Phase 2

~9240

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Radiological Society of North AmericaOTHER

25 Previous Clinical Trials

1,759 Total Patients Enrolled

University of California, IrvineLead Sponsor

544 Previous Clinical Trials

1,922,983 Total Patients Enrolled

Gelareh Sadigh, MDPrincipal InvestigatorUniversity of California, Irvine

2 Previous Clinical Trials

141 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any ongoing opportunities for individuals to enroll in this active clinical trial?

"The current status on clinicaltrials.gov shows that patient recruitment is ongoing for this particular trial. The trial was first listed on 2/12/2024 and most recently updated on 2/22/2024."

Answered by AI

What is the total number of individuals participating in this clinical investigation?

"Yes, the information available on clinicaltrials.gov shows that this investigation is presently seeking participants. The trial was initially published on February 12th, 2024 and was most recently revised on February 22nd, 2024. Recruitment efforts aim to enroll a total of 60 patients across four designated locations."

Answered by AI

Is the clinical study open to individuals who have passed their seventy-fifth year?

"The trial is seeking participants aged above 50 years and below 80 years."

Answered by AI

Is there a possibility for me to participate in this medical study?

"In this study, 60 individuals diagnosed with lung cancer aged between 50 and 80 are being sought. Crucially, candidates must satisfy the subsequent criteria: They should have an upcoming PCP appointment at any of the four University of California Irvine Health (UCI Health) primary care clinics within Orange County, encompassing two UCI federally qualified health centers; they need to be current smokers or former ones who ceased smoking in the last fifteen years as indicated by self-reported survey responses; their age has to fall within 50-80 years; a future appointment with their Primary Care Providers scheduled within one to three months is mandatory; there needs"

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Empowering Hispanic Patients' Lung Cancer Screening Uptake (Empower Latinx)

Gelareh Sadigh 2024. "Empowering Hispanic Patients' Lung Cancer Screening Uptake (Empower Latinx)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06225414.

All > Paid Studies San Diego